Effectiveness of risk minimization measures for the use of cilostazol in United Kingdom, Spain, Sweden, and Germany

PURPOSE: The purpose of the study is to evaluate the effectiveness of risk minimization measures—labeling changes and communication to health care professionals—recommended by the European Medicines Agency for use of cilostazol for the treatment of intermittent claudication in Europe. METHODS: Obser...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharmacoepidemiol Drug Saf
Main Authors: Castellsague, Jordi, Poblador‐Plou, Beatriz, Giner‐Soriano, Maria, Linder, Marie, Scholle, Oliver, Calingaert, Brian, Bui, Christine, Arana, Alejandro, Laguna, Clara, Gonzalez‐Rubio, Francisca, Roso‐Llorach, Albert, Prados‐Torres, Alexandra, Perez‐Gutthann, Susana
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6175151/
https://ncbi.nlm.nih.gov/pubmed/30043552
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pds.4584
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados